DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Fate Therapeutics, Inc. (FATE)
« Back to company indexFATE Chatter Timeline
Stock Ticker for FATE
Most Active Tweeters for FATE
| User | Tweets |
|---|---|
| @MareaInformativ | 10 |
| @AmericanBanking | 7 |
| @ConsumerFeed | 7 |
| @confcalltran | 6 |
| @ThisLincolnian | 6 |
Recent Tweets for FATE
 |
@ChartMill Besides having an excellent technical rating, $FATE also presents a decent setup pattern. https://t.co/tH00tGbXFV https://t.co/GBVBmIHXEr August 14th 2018, 8:08pm |
 |
@MareaInformativ Fate Therapeutics $FATE Announces Earnings Results, Misses Estimates By $0.05 EPS https://t.co/i4Un5C9XZB August 14th 2018, 4:08pm |
 |
@registrarjourn Fate Therapeutics $FATE Earns Outperform Rating from Wedbush https://t.co/TL3VV95pKo August 14th 2018, 10:08am |
|
@MareaInformativ Fate Therapeutics $FATE Raised to “Buy” at BidaskClub https://t.co/9LFZe82iHv August 14th 2018, 7:08am |
 |
@bbnsnews Fate Therapeutics $FATE Raised to “Buy” at BidaskClub https://t.co/bDGa39MWrB August 14th 2018, 6:08am |
 |
@TickerReport Fate Therapeutics $FATE Raised to “Buy” at BidaskClub https://t.co/djdkaORpAP August 14th 2018, 3:08am |
|
@MareaInformativ Zacks Investment Research Lowers Fate Therapeutics $FATE to Sell https://t.co/yr6xZ4g42v August 14th 2018, 1:08am |
 |
@VistaPResearch RT @VistaPResearch: Fate Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference August 14 $FATE $IBB #biotech #investing… August 13th 2018, 3:08pm |
|
@VistaPResearch Fate Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference August 14 $FATE $IBB #biotech… https://t.co/NaPawWsPYP August 13th 2018, 2:08pm |
 |
@WatchlistN Fate Therapeutics $FATE Rating Increased to Buy at BidaskClub https://t.co/ktPyJwDitA August 13th 2018, 12:08pm |
|
@MareaInformativ Fate Therapeutics Inc $FATE Expected to Post Quarterly Sales of $1.27 Million https://t.co/UM6AF0qwMj August 13th 2018, 11:08am |
 |
@EnterpriseLeade Fate Therapeutics $FATE Lowered to “Hold” at BidaskClub https://t.co/LrhBvRYcw1 August 13th 2018, 6:08am |
|
@ChartMill Looking at the yearly performance, $FATE did better than 98% of all other stocks. https://t.co/KA8AqYLfaC https://t.co/UE8X7tSfhK August 12th 2018, 6:08pm |
|
@MareaInformativ Brokerages Set Fate Therapeutics Inc $FATE Price Target at $16.17 https://t.co/WSeOR4J9bB August 12th 2018, 2:08pm |
 |
@ThisLincolnian BidaskClub Upgrades Fate Therapeutics $FATE to “Buy” https://t.co/4vhV7WpLv9 August 12th 2018, 4:08am |
 |
@ConsumerFeed Q3 2018 EPS Estimates for Fate Therapeutics Inc Reduced by Wedbush $FATE https://t.co/2mokCrJO1l August 12th 2018, 1:08am |
|
@ConsumerFeed Fate Therapeutics $FATE Upgraded to Buy at BidaskClub https://t.co/nOWIvbfQLZ August 11th 2018, 5:08pm |
 |
@TheMarketsDaily Wedbush Reiterates Outperform Rating for Fate Therapeutics $FATE https://t.co/KRqqZFAQwN August 11th 2018, 12:08pm |
|
@bbnsnews Q3 2018 Earnings Estimate for Fate Therapeutics Inc Issued By Wedbush $FATE https://t.co/aMEwvfacay August 11th 2018, 6:08am |
|
@EnterpriseLeade Somewhat Positive Press Coverage Somewhat Unlikely to Impact Fate Therapeutics $FATE Share Price https://t.co/5mQRQ36dDm August 11th 2018, 4:08am |
|
@ThisLincolnian HC Wainwright Reiterates “Hold” Rating for Fate Therapeutics $FATE https://t.co/zLmldkIHuX August 11th 2018, 4:08am |
|
@TheMarketsDaily Fate Therapeutics $FATE Earns Hold Rating from HC Wainwright https://t.co/WcvPUU08OD August 10th 2018, 5:08pm |
 |
@TranscriptDaily Fate Therapeutics $FATE Earns Outperform Rating from Wedbush https://t.co/6jQeNiLYTy August 10th 2018, 4:08pm |
 |
@dispatchtribune Fate Therapeutics $FATE Upgraded to “Hold” by Zacks Investment Research https://t.co/LpND7eEO4j August 10th 2018, 12:08pm |
 |
@dakotafinancial Q3 2018 EPS Estimates for Fate Therapeutics Inc Reduced by Analyst $FATE https://t.co/TbKHtRpoUF August 10th 2018, 7:08am |
 |
@AmericanBanking Q3 2018 EPS Estimates for Fate Therapeutics Inc Reduced by Analyst $FATE https://t.co/vxWKKZoH2q #stocks August 10th 2018, 7:08am |
 |
@bibeypost_stock Fate Therapeutics, Inc. $FATE has analysts on the Bullish side this week. - https://t.co/ybEgvBOljj August 10th 2018, 7:08am |
 |
@mmahotstuff1 Are Analysts Bearish Fate Therapeutics, Inc. $FATE After Last Week? - https://t.co/wlu6NTNoKS August 10th 2018, 7:08am |
 |
@reurope_stock Here's how analysts see Fate Therapeutics, Inc. $FATE after this past week. https://t.co/fXnzBJriQk August 10th 2018, 7:08am |
 |
@whatsonthorold2 This is what analysts have to say about Fate Therapeutics, Inc. $FATE after last week. - https://t.co/1mgaFydp4n August 10th 2018, 7:08am |
 |
@west_moreland It's been a crucial week for Fate Therapeutics, Inc. $FATE; here's what analysts have to say. https://t.co/FOhNMtolQz August 10th 2018, 7:08am |
 |
@Fanob_stock Discussion stirs around Fate Therapeutics, Inc. $FATE this week; here is what analysts are saying. https://t.co/uPMM4VfpfE August 10th 2018, 7:08am |
|
@TranscriptDaily Fate Therapeutics $FATE Lifted to “Buy” at BidaskClub https://t.co/7H6DxwPmtY August 10th 2018, 4:08am |
|
@WatchlistN Fate Therapeutics Inc $FATE Expected to Post Quarterly Sales of $1.57 Million https://t.co/0xWnKRlTtp August 9th 2018, 6:08pm |
|
@ConsumerFeed Fate Therapeutics Inc $FATE Expected to Post Earnings of -$0.28 Per Share https://t.co/5OHuJ4i2y1 August 9th 2018, 6:08pm |
|
@ThisLincolnian Fate Therapeutics $FATE Raised to “Hold” at Zacks Investment Research https://t.co/3JaENe65x6 August 9th 2018, 4:08pm |
 |
@dailypoliticaln Fate Therapeutics $FATE Stock Rating Reaffirmed by Wedbush https://t.co/3oVKTgDEBd August 9th 2018, 4:08pm |
|
@WatchlistN Fate Therapeutics $FATE Stock Rating Reaffirmed by Wedbush https://t.co/eEtgyjhVm6 August 9th 2018, 4:08pm |
|
@AmericanBanking Weekly Analysts’ Ratings Updates for Fate Therapeutics $FATE https://t.co/QNTbGn2wjZ #stocks August 9th 2018, 11:08am |
 |
@ZolmaxNews Weekly Analysts’ Ratings Updates for Fate Therapeutics $FATE https://t.co/Tp1STzVVQu August 9th 2018, 11:08am |
|
@bbnsnews Fate Therapeutics $FATE Raised to “Hold” at Zacks Investment Research https://t.co/E7ERYRG54c August 9th 2018, 9:08am |
|
@TickerReport HC Wainwright Reiterates “Hold” Rating for Fate Therapeutics $FATE https://t.co/Pws0Wdn6FP August 9th 2018, 1:08am |
|
@dailypoliticaln HC Wainwright Reiterates “Hold” Rating for Fate Therapeutics $FATE https://t.co/KKF7O0E8ie August 9th 2018, 1:08am |
|
@TickerReport HC Wainwright Reiterates “Hold” Rating for Fate Therapeutics $FATE https://t.co/B7Q4yLMEnT August 9th 2018, 1:08am |
|
@dailypoliticaln HC Wainwright Reiterates “Hold” Rating for Fate Therapeutics $FATE https://t.co/vn4zZgWYrf August 9th 2018, 1:08am |
|
@WatchlistN Fate Therapeutics Inc to Post FY2018 Earnings of -$1.25 Per Share, Piper Jaffray Companies Forecasts $FATE https://t.co/cGmagobrSB August 9th 2018, 12:08am |
|
@MareaInformativ Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Fate Therapeutics $FATE Share Price https://t.co/7AZR22WWmU August 8th 2018, 11:08pm |
|
@dispatchtribune Fate Therapeutics $FATE Issues Earnings Results https://t.co/qwMXQuuuIK August 8th 2018, 8:08pm |
 |
@Slambucket $FATE seems to have some sort of immunity to this small cap bio degenerative disease August 8th 2018, 6:08pm |
 |
@OlympiaReport Fate Therapeutics $FATE Receives Outperform Rating from Wedbush https://t.co/h3RixpQH1P August 8th 2018, 6:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.